Leticia Toledo-Sherman

Corporate Officer/Principal bei LymphoSign, Inc.

Commercial Services

Health Technology

Consumer Services

Aktive Positionen von Leticia Toledo-Sherman

Unternehmen	Position	Beginn	Ende
LymphoSign, Inc. LymphoSign, Inc. BiotechnologyHealth Technology LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada.	Corporate Officer/Principal	01.08.2004	-

Unternehmen	Position	Beginn	Ende
MDS Proteomics, Inc.	Corporate Officer/Principal	-	-
Kinetix Pharmaceuticals, Inc. Kinetix Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Kinetix Pharmaceuticals develops selective protein kinase inhibitors which block disease-causing pathways resulting from aberrant protein kinase activity	Corporate Officer/Principal	-	-

The State University of New York

Doctorate Degree

International

Kanada	3
Vereinigte Staaten	3

Operativ

Corporate Officer/Principal	3
Doctorate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	3
LymphoSign, Inc. LymphoSign, Inc. BiotechnologyHealth Technology LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada.	Health Technology
Kinetix Pharmaceuticals, Inc. Kinetix Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Kinetix Pharmaceuticals develops selective protein kinase inhibitors which block disease-causing pathways resulting from aberrant protein kinase activity	Commercial Services
MDS Proteomics, Inc.	Commercial Services